An Audit of Patients With Crohn's Disease Treated With Infliximab (P06066)
NCT00988832
·
clinicaltrials.gov ↗
COMPLETED
Status
380
Enrollment
INDUSTRY
Sponsor class
Conditions
Crohn's Disease
Interventions
BIOLOGICAL:
Infliximab
Sponsor
Merck Sharp & Dohme LLC